[1] Bilynskyj BT.The breast cancer treatment as a marker of progress in oncology[J].Exp Oncol,2010,32(3):190-194.
[2] Tavassoli FA,Devilee P.Pathology and genetics of tumours of the breast and female genital organs[M].Lyon:IARC Press,2003:10-80.
[3] Xiong Y,Cao LP,Rao HL,et al.Clinical significance of peritumor lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-Ⅱa squmous cell cervical cancer[J].Cell Tissue Res,2012,348(3):515-522.
[4] Achen MG,Jeltsch M,Kukk E.et al.Vascular endothelial growth factor(VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk 1)and VEGF receptor 39(Flt 4)[J].Proc Natl Acad Sci USA,1998,95(2):548-553.
[5] 邓恋.淋巴管新生与肿瘤转移的研究进展[J].实用癌症杂志,2013,28(1):95-97.
[6] 施华球,鄢俊,王祥财.VEGF-D与其受体在结直肠癌中的表达及与淋巴管生成的关系[J].山东医药,2010,50(1):38-39.
[7] 杨泽妹,徐海霞.血管内皮生长因子及其受体在子宫内膜癌中的表达及对淋巴管生成的作用[J].中国老年学杂志,2010,30(15):2117-2118.
[8] Schimanski C,Schlaegel F,Jordan M.VEGF-D correlates with metastatic disease in gastric cancer patients undergoing surgery[J].World J Surg,2011,35(5):1010-1016.
[9] 朱勇杰,师晓莉,沈妮娜,等.血管内皮生长因子VEGF-C和VEGF-D在卵巢上皮癌的表达及其预后研究[J].新疆医科大学学报,2014,27(12):1591-1594.
[10] Nakamura Y,Yasuoka H,TsuJimoto M,et al.Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up[J].Clin Cancer Ras,2003,9(2):716-721.
[11]
[12] Sotiropoulou N,Bravou V,Kounelis S,et al.Tumor expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression[J].Pathology,2010,42(7):629-636.
[13] Price TJ,Hardingham JE,Lee CK,et al.Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer(CRC) receiving bevacizumab[J].Cancer Med,2013,2(3):177-285.
[14] 李敬东,梁锐英,赵艳萍,等.牙龈癌中VEGF及PTEN的表达及其相关性分析[J].上海口腔医学,2014,23(5):619-623.